(Q45736192)

15 December 2017

title

Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody (English)

1 reference

15 December 2017

1 reference

7

1 reference

15 December 2017

Emanuele Cozzi

6

0 references

author name string

Giulia Ghirardo

1

1 reference

15 December 2017

Elisa Benetti

2

1 reference

15 December 2017

Francesca Poli

3

1 reference

15 December 2017

Enrico Vidal

4

1 reference

15 December 2017

Manuela Della Vella

5

1 reference

15 December 2017

publication date

25 November 2013

1 reference

Pediatric Transplantation

15 December 2017

published in

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

E1-5

1 reference

Current approaches to the management of highly sensitized kidney transplant patients

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Advances in diagnosing and managing antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Desensitization in HLA-incompatible kidney recipients and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Successful renal re-transplantation in the presence of pre-existing anti-DQ5 antibodies when there was zero mismatch at class I human leukocyte antigen A, B, & C: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Detection and clinical relevance of donor specific HLA antibodies: a matter of debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Intravenous immunoglobulin a natural regulator of immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Current approaches to treatment of antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPETR.12187

21 January 2018

Identifiers

DOI

10.1111/PETR.12187

1 reference

15 December 2017

1 reference